Vittoria Biotherapeutics Completes $25 Million Financing for Innovative Therapies

Deal News | Nov 12, 2024 | Ben Franklin Technology Partne

Vittoria Biotherapeutics Completes $25 Million Financing for Innovative Therapies

Vittoria Biotherapeutics, a clinical-stage immunotherapy company, announced the successful completion of a $25 million private financing round aimed at boosting the development of its innovative cell therapies. This new funding includes a $10 million extension to its previous $15 million financing round completed in November 2023. The financing effort underscores Vittoria Biotherapeutics' commitment to advancing groundbreaking treatments for hard-to-treat diseases. The investment highlights the interest of private equity firms like Ben Franklin Technology Partners in supporting pioneering developments in biotechnology.

Sectors

  • Biotechnology
  • Private Equity
  • Healthcare

Geography

  • United States – Vittoria Biotherapeutics and Ben Franklin Technology Partners are based in the United States, specifically engaging in activities in Philadelphia.
  • Philadelphia – Philadelphia is mentioned as the location of Vittoria Biotherapeutics, emphasizing its geographical base.

Industry

  • Biotechnology – The biotechnology industry is relevant as Vittoria Biotherapeutics is involved in developing innovative cell therapies.
  • Private Equity – Ben Franklin Technology Partners is a participant in the financing, representing the active role of private equity in supporting biotechnology advancements.
  • Healthcare – Vittoria Biotherapeutics' focus on treatments for hard-to-treat diseases places it within the healthcare sector.

Financials

  • $25 million – Total amount of the latest private financing round completed by Vittoria Biotherapeutics.
  • $10 million – The extension amount to the previous $15 million financing round secured by Vittoria Biotherapeutics in November 2023.

Participants

NameRoleTypeDescription
Vittoria Biotherapeutics, Inc.Target CompanyCompanyA clinical-stage immunotherapy company developing innovative cell therapies.
Ben Franklin Technology PartnersInvestorCompanyA regional initiative of the Pennsylvania Department of Community and Economic Development providing funding to enterprises.